Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CCNL1 |
| Upstream (Parents) |
|---|
| (<<) AVP → CCNL1 |
| (<<) CAMKK1 → CCNL1 |
| (<<) CSNK1A1 → CCNL1 |
| (<<) CYB561D1 → CCNL1 |
| (<<) DAB2 → CCNL1 |
| (<<) DOCK9 → CCNL1 |
| (<<) DUSP1 → CCNL1 |
| (<<) FAM48A → CCNL1 |
| (<<) HDAC3 → CCNL1 |
| (<<) ILKAP → CCNL1 |
| (<<) JAK2 → CCNL1 |
| (<<) MEF2A → CCNL1 |
| (<<) PDE2A → CCNL1 |
| (<<) PIK3C2B → CCNL1 |
| (<<) PIK3CA → CCNL1 |
| (<<) PIK3R2 → CCNL1 |
| (<<) PRKAA1 → CCNL1 |
| (<<) PRKX → CCNL1 |
| (<<) PROCA1 → CCNL1 |
| (<<) PRPF4B → CCNL1 |
| (<<) PTEN → CCNL1 |
| (<<) RNASE7 → CCNL1 |
| (<<) SLC20A1 → CCNL1 |
| (<<) SUFU → CCNL1 |
| (<<) TSC22D1 → CCNL1 |
| Downstream (Children) |
|---|
| CCNL1 → BAALC (>>) |
| CCNL1 → CASC4 (>>) |
| CCNL1 → CDC42EP2 (>>) |
| CCNL1 → EP300 (>>) |
| CCNL1 → FCRLB (>>) |
| CCNL1 → GNA11 (>>) |
| CCNL1 → GPR153 (>>) |
| CCNL1 → HS3ST1 (>>) |
| CCNL1 → ITGA3 (>>) |
| CCNL1 → MMP15 (>>) |
| CCNL1 → PITPNC1 (>>) |
| CCNL1 → PKIG (>>) |
| CCNL1 → RAF1 (>>) |
| CCNL1 → YWHAB (>>) |
